Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

NCT03727022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: Placebo
DRUG: SM04690

Sponsor

Biosplice Therapeutics, Inc.